Patents Assigned to Pierce Biotechnology, Inc.
-
Patent number: 8889884Abstract: A phosphine derivative of DyLight dyes modified with ethylene glycol or (poly)ethylene glycol groups. In one embodiment, the compounds are useful in chemoselective ligation reactions.Type: GrantFiled: July 11, 2012Date of Patent: November 18, 2014Assignees: Pierce Biotechnology, Inc., Dyomics GmbHInventors: Greg Hermanson, Peter T. Czerney, Surbhi Desai, Suk J. Hong, Matthias S. Wenzel, Boguslawa Dworecki, Frank G. Lehmann
-
Publication number: 20140076811Abstract: A dialysis device, and a method of dialyzing a sample, are provided. The dialysis device includes a body having a first and a second major side, a first and a second retaining ring disposed on the first and second major sides, and a first and second dialysis membrane disposed, and held between the first and second major sides and the first and second retaining rings. The dialysis device is configured to receive a sample to enable dialysis of the sample across the membranes.Type: ApplicationFiled: September 14, 2012Publication date: March 20, 2014Applicant: Pierce Biotechnology, Inc.Inventors: Paul Jeffrey Haney, Jeffery James Frank Gordon, Brendan George Metz, Navid R. Haghdoost
-
Publication number: 20130316330Abstract: The present invention relates to a non-toxic dipolar solvent for chromogenic substrate for detecting presence of lacZ gene and/or gene activity, which comprises a stabilizing amount of a solubilizing agent. The present invention also relates to a method for inducing lac operon in screening assay, comprising the step of contacting an agar plate with at least one essential oil in a concentration sufficient to induce the lac operon. The present invention further relates to a method for detecting the presence of bacteria, comprising the step of contacting an agar plate with at least one essential oil in a concentration sufficient to induce detection of the bacteria.Type: ApplicationFiled: August 5, 2013Publication date: November 28, 2013Applicant: Pierce Biotechnology, Inc.Inventors: Pierre Sévigny, Martina Bielefeld-Sévigny
-
Publication number: 20130309689Abstract: Methods and sets of non-biological reagents (elution reagents, tag isomers, tag reactive groups, crosslinkers) for single or multiplexed capture and gentle elution of biomolecules. Examples are provided using amine- and cysteine-reactive reagents for enrichment of proteins, peptides, and rare peptide modifications.Type: ApplicationFiled: March 11, 2013Publication date: November 21, 2013Applicant: Pierce Biotechnology, Inc.Inventors: John Charles Rogers, Ryan Daniel Bomgarden, Christopher Laurence Etienne, Eric Leigh Hommema
-
Patent number: 8572507Abstract: Systems and methods to provide users with a user interface at the point of use that provides customizable, interactive protocols, where a protocol is typically an instruction set, procedure, or methodology.Type: GrantFiled: March 17, 2011Date of Patent: October 29, 2013Assignee: Pierce Biotechnology, Inc.Inventors: Kevin Abrams, Douglas Hayworth
-
Publication number: 20130251637Abstract: Compounds used as labels with properties comparable to known fluorescent compounds. The compounds can be conjugated to proteins and nucleic acids for biological imaging and analysis. Synthesis of the compounds, formation and use of the conjugated compounds, and specific non-limiting examples of each are provided.Type: ApplicationFiled: December 20, 2011Publication date: September 26, 2013Applicants: DYOMICS GMBH, PIERCE BIOTECHNOLOGY, INC.Inventors: Greg Hermanson, Peter T. Czerney, Surbhi Desai, Matthias S. Wenzel, Boguslawa Dworecki, Frank G. Lehmann
-
Patent number: 8536323Abstract: Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays.Type: GrantFiled: April 20, 2011Date of Patent: September 17, 2013Assignee: Pierce Biotechnology, Inc.Inventors: Kay Opperman, Barbara J. Kaboord, Jean-Samuel Schultz, Christopher L. Etienne, Greg Hermanson
-
Patent number: 8507291Abstract: A method to remove detergents from a biological protein sample that is to be analyzed by mass spectroscopy (MS). The method uses a high performance cyclodextrin polymer resin to remove detergents, which interfere with MS analysis, from a sample containing proteins, peptides, amino acids, etc.Type: GrantFiled: May 18, 2010Date of Patent: August 13, 2013Assignee: Pierce Biotechnology, Inc.Inventors: Babu S. Antharavally, A. Krishna Mallia, Ashok Salunkhe
-
Patent number: 8501433Abstract: The present invention relates to a non-toxic dipolar solvent for chromogenic substrate for detecting presence of lacZ gene and/or gene activity, which comprises a stabilizing amount of a solubilizing agent. The present invention also relates to a method for inducing lac operon in screening assay, comprising the step of contacting an agar plate with at least one essential oil in a concentration sufficient to induce the lac operon. The present invention further relates to a method for detecting the presence of bacteria, comprising the step of contacting an agar plate with at least one essential oil in a concentration sufficient to induce detection of the bacteria.Type: GrantFiled: October 31, 2003Date of Patent: August 6, 2013Assignee: Pierce Biotechnology, Inc.Inventors: Pierre Sévigny, Martina Bielefeld-Sévigny
-
Publication number: 20130045488Abstract: Compounds useful as labels with properties comparable to known fluorescent compounds. The compounds are conjugated to proteins and nucleic acids for biological imaging and analysis. Synthesis of the compounds, formation and use of the conjugated compounds, and specific non-limiting examples of each are provided.Type: ApplicationFiled: August 10, 2012Publication date: February 21, 2013Applicants: Dyomics GmbH, Pierce Biotechnology, Inc.Inventors: Greg Hermanson, Peter T. Czerney, Surbhi Desai, Matthias S. Wenzel, Boguslawa Dworecki, Frank G. Lehmann, Marie Christine Nlend
-
Publication number: 20130034867Abstract: Methods for producing an isotope-labeled mammalian, including a human, biomolecule, such as polypeptides and proteins, in a cell-free protein synthesis system. A biomolecule standard is produced having at least one isotope different in abundance than that of the naturally occurring isotopes in the biomolecule. Methods for quantifying biomolecules standards expressed using mammalian cell-free extracts are disclosed. Methods for producing such standards, kits, systems and reagents, relating to the use of isotope-labeled biomolecule as quantification standards in mass spectrometric and nuclear magnetic resonance analysis.Type: ApplicationFiled: August 2, 2012Publication date: February 7, 2013Applicant: Pierce Biotechnology, Inc.Inventors: Ryan D. Bomgarden, Eric Leigh Hommema, John Charles Rogers, Penny JoAnn Jensen, Derek Karl Baerenwald
-
Publication number: 20120294807Abstract: Compounds used as labels with properties comparable to known fluorescent compounds. The compounds can be conjugated to proteins and nucleic acids for biological imaging and analysis. Synthesis of the compounds, formation and use of the conjugated compounds, and specific non-limiting examples of each are provided.Type: ApplicationFiled: December 20, 2011Publication date: November 22, 2012Applicants: DYOMICS GMBH, PIERCE BIOTECHNOLOGY, INC.Inventors: Greg Hermanson, Peter T. Czerney, Surbhi Desai, Matthias S. Wenzel, Boguslawa Dworecki, Frank G. Lehmann
-
Publication number: 20120252691Abstract: Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays.Type: ApplicationFiled: May 29, 2012Publication date: October 4, 2012Applicant: Pierce Biotechnology, Inc.Inventors: Christopher L. Etienne, Kay K. Opperman, Barbara J. Kaboord, Scott Meier, Jean-Samuel Schultz
-
Publication number: 20120217203Abstract: A dialysis system including a generally sealed vessel configured to receive a buffer, and a dialysis device positioned in the generally sealed vessel. The dialysis device includes an inner member and an outer member trapping a dialysis membrane between the members. The dialysis device is configured to receive a sample to enable dialysis of the sample with respect to the buffer across the membrane.Type: ApplicationFiled: January 6, 2012Publication date: August 30, 2012Applicant: Pierce Biotechnology, Inc.Inventors: Paul Jeffrey Haney, Brian L. Webb, Navid Reza Haghdoost, Rizwan Farooqui, Atul Madhukar Deshpande
-
Publication number: 20120156140Abstract: Compounds used as labels with properties comparable to known fluorescent compounds. The compounds can be conjugated to proteins and nucleic acids for biological imaging and analysis. Synthesis of the compounds, formation and use of the conjugated compounds, and specific non-limiting examples of each are provided.Type: ApplicationFiled: December 20, 2011Publication date: June 21, 2012Applicants: DYOMICS GMBH, PIERCE BIOTECHNOLOGY, INC.Inventors: Greg Hermanson, Peter T. Czerney, Surbhi Desai, Matthias S. Wenzel, Boguslawa Dworecki, Frank G. Lehmann
-
Patent number: 8192948Abstract: A kit for enhanced detection of analytes that produce peroxide or peroxidase activity.Type: GrantFiled: April 17, 2009Date of Patent: June 5, 2012Assignee: Pierce Biotechnology, Inc.Inventor: Kelli D. Feather-Henigan
-
Publication number: 20110289442Abstract: Systems and methods to provide users with a user interface at the point of use that provides customizable, interactive protocols, where a protocol is typically an instruction set, procedure, or methodology.Type: ApplicationFiled: March 17, 2011Publication date: November 24, 2011Applicant: Pierce Biotechnology, Inc.Inventors: Kevin Abrams, Douglas Hayworth
-
Publication number: 20110262917Abstract: Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays.Type: ApplicationFiled: April 20, 2011Publication date: October 27, 2011Applicant: PIERCE BIOTECHNOLOGY, INC.Inventors: Kay Opperman, Barbara J. Kaboord, Jean-Samuel Schultz, Christopher L. Etienne, Greg Hermanson
-
Patent number: 8039648Abstract: Compounds used as dyes comparable to Alexa Fluor 350 dyes. The inventive compounds have high fluorescence quantum yield and high photostability. The dyes facilitate analysis of biological structures with enhanced sensitivity and selectivity.Type: GrantFiled: June 16, 2009Date of Patent: October 18, 2011Assignee: Pierce Biotechnology, Inc.Inventors: Peter T. Czerney, Surbhi Desai, Matthias S. Wenzel, Boguslawa Dworecki, Frank G. Lehmann, Bernd G. Schweder, Wilhelm G. Frank
-
Patent number: 8007668Abstract: A device for dialysis of a sample includes a sample chamber formed by a gasket and dialysis membranes affixed to each side of the gasket in facing relationship. A housing supports the dialysis membranes and gasket. An air chamber causes the device to float in a generally upright position when the device is immersed in a dialysate. An access port is provided through the gasket and between the dialysis membranes. The access port is accessible from outside the housing and in communication with the sample chamber such that a dispensing end of a dispensing device can be inserted through the access port to dispense sample into the sample chamber. In one embodiment, the gasket is impermeable or essentially impermeable to the sample being dialyzed.Type: GrantFiled: February 5, 2009Date of Patent: August 30, 2011Assignee: Pierce Biotechnology, Inc.Inventors: Paul J. Haney, Michael Robert Johnston